Polygenic dissection of treatment-resistant depression with proxy phenotypes in the UK Biobank

CONCLUSIONS: Our findings support a significant polygenic basis for TRD, highlighting genetic and phenotypic distinctions from non-TRD. We demonstrate that different TRD(p) endpoints are enriched with various spectra of psychiatric genetic liability, offering insights into pharmacogenomics and TRD’s complex genetic architecture.

via https://pubmed.ncbi.nlm.nih.gov/40187433/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1L37KAMf2b_g4WEK3LmdFuKZu9pO3cN7u4ZmO9PPCPeBLMIw1q&fc=None&ff=20250417010903&v=2.18.0.post9+e462414